286 related articles for article (PubMed ID: 32753690)
41. [Mutational analysis of RNA splicing machinery genes SF3B1, U2AF1 and SRSF2 in 118 patients with myelodysplastic syndromes and related diseases].
Wang JY; Ma J; Lin YN; Wang J; Shen H; Gui FM; Han C; Li QH; Song Z; Wang XJ
Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):192-197. PubMed ID: 28395441
[No Abstract] [Full Text] [Related]
42. Development of a high-resolution melting curve analysis screening test for SRSF2 splicing factor gene mutations in myelodysplastic syndromes.
Garza E; Fabiani E; Noguera N; Panetta P; Piredda ML; Borgia L; Maurillo L; Catalano G; Voso MT; Lo-Coco F
J Mol Diagn; 2015 Jan; 17(1):85-9. PubMed ID: 25445211
[TBL] [Abstract][Full Text] [Related]
43. Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia.
Bamopoulos SA; Batcha AMN; Jurinovic V; Rothenberg-Thurley M; Janke H; Ksienzyk B; Philippou-Massier J; Graf A; Krebs S; Blum H; Schneider S; Konstandin N; Sauerland MC; Görlich D; Berdel WE; Woermann BJ; Bohlander SK; Canzar S; Mansmann U; Hiddemann W; Braess J; Spiekermann K; Metzeler KH; Herold T
Leukemia; 2020 Oct; 34(10):2621-2634. PubMed ID: 32358566
[TBL] [Abstract][Full Text] [Related]
44. The significance of spliceosome mutations in chronic lymphocytic leukemia.
Rozovski U; Keating M; Estrov Z
Leuk Lymphoma; 2013 Jul; 54(7):1364-6. PubMed ID: 23270583
[TBL] [Abstract][Full Text] [Related]
45. Impact of Splicing Factor Mutations on Pre-mRNA Splicing in the Myelodysplastic Syndromes.
Yip BH; Dolatshad H; Roy S; Pellagatti A; Boultwood J
Curr Pharm Des; 2016; 22(16):2333-44. PubMed ID: 26916023
[TBL] [Abstract][Full Text] [Related]
46. The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts.
Kang MG; Kim HR; Seo BY; Lee JH; Choi SY; Kim SH; Shin JH; Suh SP; Ahn JS; Shin MG
BMC Cancer; 2015 Jun; 15():484. PubMed ID: 26115659
[TBL] [Abstract][Full Text] [Related]
47. Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling.
Taskesen E; Havermans M; van Lom K; Sanders MA; van Norden Y; Bindels E; Hoogenboezem R; Reinders MJ; Figueroa ME; Valk PJ; Löwenberg B; Melnick A; Delwel R
Blood; 2014 May; 123(21):3327-35. PubMed ID: 24668493
[TBL] [Abstract][Full Text] [Related]
48. Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.
Dolatshad H; Pellagatti A; Fernandez-Mercado M; Yip BH; Malcovati L; Attwood M; Przychodzen B; Sahgal N; Kanapin AA; Lockstone H; Scifo L; Vandenberghe P; Papaemmanuil E; Smith CW; Campbell PJ; Ogawa S; Maciejewski JP; Cazzola M; Savage KI; Boultwood J
Leukemia; 2015 May; 29(5):1092-103. PubMed ID: 25428262
[TBL] [Abstract][Full Text] [Related]
49. Epigenetic modifications of splicing factor genes in myelodysplastic syndromes and acute myeloid leukemia.
Wong JJ; Lau KA; Pinello N; Rasko JE
Cancer Sci; 2014 Nov; 105(11):1457-63. PubMed ID: 25220401
[TBL] [Abstract][Full Text] [Related]
50. Validation of the WHO 2016 proposals for Myelodysplastic syndromes patients with the presence of ring sideroblasts but without excess blasts.
Li Y; Cui R; Qin T; Xu Z; Zhang Y; Cai W; Cui W; Liu J; Li B; Xiao Z
Br J Haematol; 2017 Sep; 178(5):813-816. PubMed ID: 27292319
[No Abstract] [Full Text] [Related]
51. Alternatively spliced CSF3R isoforms in SRSF2 P95H mutated myeloid neoplasms.
Wang BA; Mehta HM; Penumutchu SR; Tolbert BS; Cheng C; Kimmel M; Haferlach T; Maciejewski JP; Corey SJ
Leukemia; 2022 Oct; 36(10):2499-2508. PubMed ID: 35941213
[TBL] [Abstract][Full Text] [Related]
52. NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.
Forghieri F; Paolini A; Morselli M; Bigliardi S; Bonacorsi G; Leonardi G; Coluccio V; Maccaferri M; Fantuzzi V; Faglioni L; Colaci E; Soci F; Nasillo V; Messerotti A; Arletti L; Pioli V; Zucchini P; Quadrelli C; Corradini G; Giacobbi F; Vallerini D; Riva G; Barozzi P; Lagreca I; Marasca R; Narni F; Mecucci C; Ottaviani E; Martinelli G; Falini B; Luppi M; Potenza L
Leuk Lymphoma; 2015; 56(11):3222-6. PubMed ID: 25813079
[No Abstract] [Full Text] [Related]
53. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
[TBL] [Abstract][Full Text] [Related]
54. Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.
Sakr R; Renneville A; Saada V; Cotteret S; Martin JE; Droin N; Selimoglu-Buet D; Besse B; Hollebecque A; Marzac C; Pasquier F; Micol JB; De Botton S; Mir O; Solary E; Willekens C
Leuk Lymphoma; 2018 Jul; 59(7):1742-1745. PubMed ID: 29115897
[No Abstract] [Full Text] [Related]
55. [Ineffective erythropoiesis in myelodysplastic syndrome].
Iwama A
Rinsho Ketsueki; 2018; 59(6):793-797. PubMed ID: 29973461
[TBL] [Abstract][Full Text] [Related]
56. Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia.
Hou HA; Liu CY; Kuo YY; Chou WC; Tsai CH; Lin CC; Lin LI; Tseng MH; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Li CC; Huang SY; Ko BS; Hsu SC; Chen CY; Lin CT; Wu SJ; Tsay W; Tien HF
Oncotarget; 2016 Feb; 7(8):9084-101. PubMed ID: 26812887
[TBL] [Abstract][Full Text] [Related]
57. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.
Kesarwani AK; Ramirez O; Gupta AK; Yang X; Murthy T; Minella AC; Pillai MM
Oncogene; 2017 Feb; 36(8):1123-1133. PubMed ID: 27524419
[TBL] [Abstract][Full Text] [Related]
58. Integrative RNA-omics Discovers GNAS Alternative Splicing as a Phenotypic Driver of Splicing Factor-Mutant Neoplasms.
Wheeler EC; Vora S; Mayer D; Kotini AG; Olszewska M; Park SS; Guccione E; Teruya-Feldstein J; Silverman L; Sunahara RK; Yeo GW; Papapetrou EP
Cancer Discov; 2022 Mar; 12(3):836-855. PubMed ID: 34620690
[TBL] [Abstract][Full Text] [Related]
59. U2AF65-Dependent SF3B1 Function in SMN Alternative Splicing.
Choi N; Liu Y; Oh J; Ha J; Zheng X; Shen H
Cells; 2020 Dec; 9(12):. PubMed ID: 33317029
[TBL] [Abstract][Full Text] [Related]
60. Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations.
Flach J; Jann JC; Knaflic A; Riabov V; Streuer A; Altrock E; Xu Q; Schmitt N; Obländer J; Nowak V; Danner J; Mehralivand A; Hofmann F; Palme I; Jawhar A; Wuchter P; Metzgeroth G; Nolte F; Hofmann WK; Nowak D
Haematologica; 2021 Nov; 106(11):2906-2917. PubMed ID: 33054116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
